Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis
- PMID: 21571570
- PMCID: PMC5199613
- DOI: 10.1016/j.parkreldis.2011.04.016
Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis
Abstract
Background: Although orthostatic hypotension (OH) is recognized as one of the main non-motor symptoms of Parkinson's disease (PD), there is inconsistent evidence about the prevalence of OH in PD. To estimate the prevalence of OH in PD more precisely we conducted a systematic review of the literature.
Methods: From PubMed and Embase searches with predefined inclusion criteria, we identified studies published up till December 2009. Prevalence numbers from studies were pooled using a non-linear random-effects meta-analysis.
Results: We found 25 studies from which the prevalence of OH could be calculated. The pooled estimate of the point prevalence of OH in PD was 30.1% (95% CI: 22.9% to 38.4%). We found a large statistical heterogeneity between studies which could not be reduced by several subgroup analyses.
Conclusions: The estimated prevalence of OH in PD is 30%. However, due to the large heterogeneity between studies this pooled estimate should be interpreted with caution. More data from unselected population-based cohorts are needed.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Selegiline for Alzheimer's disease.Cochrane Database Syst Rev. 2003;(1):CD000442. doi: 10.1002/14651858.CD000442. Cochrane Database Syst Rev. 2003. PMID: 12535396
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2. Cochrane Database Syst Rev. 2021. PMID: 35608903 Free PMC article.
-
Inhaled mannitol for cystic fibrosis.Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 May 1;5:CD008649. doi: 10.1002/14651858.CD008649.pub4. PMID: 29424930 Free PMC article. Updated.
Cited by
-
Parkinson disease primer, part 2: management of motor and nonmotor symptoms.Can Fam Physician. 2023 Feb;69(2):91-96. doi: 10.46747/cfp.690291. Can Fam Physician. 2023. PMID: 36813521 Free PMC article.
-
Impact of orthostatic hypotension on wheelchair use in patients with Parkinson's disease.J Neural Transm (Vienna). 2020 Mar;127(3):379-383. doi: 10.1007/s00702-019-02127-4. Epub 2019 Dec 23. J Neural Transm (Vienna). 2020. PMID: 31873768
-
Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.J Bioenerg Biomembr. 2019 Jun;51(3):175-188. doi: 10.1007/s10863-019-09798-4. Epub 2019 May 3. J Bioenerg Biomembr. 2019. PMID: 31054074 Free PMC article. Review.
-
Gravitational syncope induced by rising elevators in a Parkinson's disease patient.J Mov Disord. 2023 Sep;16(3):331-332. doi: 10.14802/jmd.23076. Epub 2023 Jun 9. J Mov Disord. 2023. PMID: 37291834 Free PMC article. No abstract available.
-
Fluid and Biopsy Based Biomarkers in Parkinson's Disease.Neurotherapeutics. 2023 Jul;20(4):932-954. doi: 10.1007/s13311-023-01379-z. Epub 2023 May 3. Neurotherapeutics. 2023. PMID: 37138160 Free PMC article. Review.
References
-
- Hely MA, Morris JGL, Reid WGJ, Trafficante R. Sydney multicenter study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20:190–9. - PubMed
-
- Goldstein DS. Dysautonomia in Parkinson’s disease: neurocardiological abnormalities. Lancet Neurol. 2003;2:669–76. - PubMed
-
- Smit AA, Wieling W, Opfer-Gehrking TL, van Emmerik-Levelt HM, Low PA. Patients’ choice of portable folding chairs to reduce symptoms of orthostatic hypotension. Clin Auton Res. 1999;9:341–4. - PubMed
-
- Wieling W, Thijs RD, van DN, Wilde AA, Benditt DG, van Dijk JG. Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain. 2009;132:2630–42. - PubMed
-
- Arbogast SD, Alshekhlee A, Hussain Z, McNeeley K, Chelimsky TC. Hypotension unawareness in profound orthostatic hypotension. Am J Med. 2009;122:574–80. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical